Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 31 | 1 | 2 | 1 | €839.60 | €954.29 | 13.661% |
| Amgen Inc. | 23 | 0 | 2 | 0 | €245.60 | €293.65 | 19.563% |
| UnitedHealth Group Inc. | 33 | 1 | 2 | 0 | €459.50 | €543.72 | 18.329% |
| Eli Lilly Corp. | 47 | 0 | 1 | 0 | €698.90 | €755.83 | 8.146% |
| Vertex Pharmaceuticals Inc. | 39 | 2 | 1 | 0 | €368.70 | €382.71 | 3.799% |
| Edwards Lifesciences Corp. | 24 | 1 | 1 | 0 | €81.23 | €87.81 | 8.096% |
| HCA Holdings Inc. | 19 | 0 | 1 | 0 | €279.00 | €289.08 | 3.611% |
| AbbVie Inc. | 18 | 1 | 1 | 0 | €153.54 | €175.79 | 14.490% |
| Boston Scientific | 37 | 0 | 1 | 0 | €63.50 | €61.53 | -3.109% |
| Koninklijke Philips Electronics | 2 | 0 | 1 | 0 | €18.65 | €20.00 | 7.267% |
| Centene Corp. | 13 | 0 | 1 | 0 | €69.30 | €82.26 | 18.695% |
| Universal Health Services B | 9 | 4 | 1 | 0 | €145.00 | €159.70 | 10.141% |
| Stryker Corp. | 17 | 0 | 1 | 0 | €306.10 | €331.52 | 8.306% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €116.00 | €130.00 | 12.069% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €66.56 | €79.30 | 19.142% |
| Fresenius SE & Co. KGaA | 4 | 1 | 0 | 0 | €26.40 | - | - |
| Hologic Inc. | 13 | 0 | 0 | 0 | €71.00 | €84.03 | 18.355% |
| Laboratory Corp. Of America (labcorp) | 9 | 0 | 0 | 0 | €188.00 | €238.36 | 26.785% |
| Idexx Laboratories Inc. | 10 | 0 | 0 | 0 | €444.90 | €557.75 | 25.366% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €128.35 | €165.00 | 28.555% |
| Align Technology | 12 | 2 | 0 | 0 | €280.20 | €342.51 | 22.237% |
| Merck & Co. Inc. | 27 | 1 | 0 | 0 | €116.00 | €124.92 | 7.686% |
| Medtronic plc | 11 | 1 | 0 | 0 | €73.93 | €94.38 | 27.662% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €197.85 | €204.50 | 3.361% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |